| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Revenues: | |||||||||
Revenues | |||||||||
31,432 | 21,193 | 151,856 | 8,152 | - | - | - | - | - | - |
Grant | |||||||||
- | - | - | - | 1,530 | 488 | 452 | 584 | 329 | 659 |
Royalty and license | |||||||||
- | - | - | - | 0 | 0 | - | - | - | - |
Sales and services | |||||||||
- | - | - | - | 3,060 | 3,337 | 8 | 0 | - | - |
Collaboration and reimbursable research and development costs | |||||||||
- | - | - | - | - | - | - | - | 200 | 23 |
Total revenues | |||||||||
- | - | - | - | 4,590 | 3,825 | 460 | 584 | 529 | 682 |
Operating costs and expenses: | |||||||||
Cost of products sold and services | |||||||||
- | - | - | 811 | 1,950 | 2,043 | 4 | 0 | - | - |
Research and development | |||||||||
106,879 | 76,963 | 55,532 | 42,175 | 31,343 | 23,983 | 9,017 | 3,830 | - | - |
Acquired in-process research and development | |||||||||
75,301 | 11,304 | 26,102 | - | - | - | - | - | - | - |
Acquired in-process research and development | |||||||||
- | - | - | 45,000 | 24,013 | 209 | 5,986 | - | 2,570 | 1,392 |
Acquired in-process research and development | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Selling, general and administrative | |||||||||
103,557 | 63,638 | 38,332 | 24,219 | 20,132 | 9,987 | 6,317 | 1,606 | 1,201 | 1,102 |
Intangible amortization | |||||||||
3,941 | 3,009 | 2,610 | 845 | 1,157 | 2,345 | 804 | 0 | - | - |
(Gain) Loss on contingent liabilities and acquisition consideration payable | |||||||||
-11,090 | 9,644 | 0 | - | - | - | - | - | - | - |
Loss on contingent liabilities and acquisition consideration payable | |||||||||
- | - | - | -8,121 | 0 | 0 | - | - | - | - |
Total operating costs and expenses | |||||||||
290,825 | 171,618 | 126,521 | 104,929 | 78,595 | 38,567 | 22,128 | 5,436 | - | - |
Total expenses | |||||||||
- | - | - | - | - | - | - | - | 3,771 | 2,494 |
Loss from operations | |||||||||
-259,393 | -150,425 | 25,335 | -96,777 | -74,005 | -34,742 | -21,668 | -4,852 | -3,242 | -1,812 |
(Loss) gain on trading securities | |||||||||
-203 | -144 | -665 | 356 | - | - | - | - | - | - |
Loss on partial debt settlement | |||||||||
-27,800 | -8,089 | -4,275 | -222 | 0 | 0 | - | - | - | - |
Trading Securities, Realized Gain (Loss) | |||||||||
- | - | - | - | 0 | 0 | - | - | - | - |
Gain on trading securities | |||||||||
- | - | - | - | - | 0 | - | - | - | - |
Gain on sale of IgDraSol, net | |||||||||
- | - | - | - | 69,274 | 0 | 0 | - | - | - |
Gain (loss) on derivative liabilities | |||||||||
-36,800 | 2,830 | 0 | 5,520 | -3,360 | 0 | - | - | - | - |
Gain on marketable securities | |||||||||
- | - | - | 27,193 | 0 | - | - | - | - | - |
(Loss) gain on foreign currency exchange | |||||||||
-330 | -1,243 | -178 | 0 | 0 | - | - | - | - | - |
Interest expense | |||||||||
36,139 | 57,631 | 4,980 | 1,610 | 1,652 | 1,629 | 253 | 0 | - | - |
Interest income | |||||||||
1,091 | 921 | 241 | 272 | 24 | 12 | 10 | 7 | 5 | 3 |
Loss on receivable | |||||||||
0 | 0 | -163 | 0 | 0 | - | - | - | - | - |
Loss before income tax | |||||||||
- | - | - | - | -9,719 | -36,359 | -21,911 | - | - | - |
Loss before income tax | |||||||||
-359,576 | -213,781 | 15,315 | -65,268 | - | - | - | -4,845 | - | - |
Income tax benefit | |||||||||
-473 | -6,274 | -36,038 | -896 | 36,314 | -1,702 | 0 | 0 | - | - |
Loss on derivative liability | |||||||||
- | - | - | - | - | - | 0 | - | - | - |
Loss on equity method investments | |||||||||
-3,909 | -5,019 | -40,244 | 435 | -4,041 | 0 | 0 | - | - | - |
Net loss | |||||||||
-363,012 | -212,526 | 11,109 | -63,937 | -50,074 | -34,657 | -21,911 | - | - | - |
Net loss attributable to noncontrolling interests | |||||||||
-70,944 | -8,986 | 1,977 | -3,014 | -4,263 | 0 | 0 | - | - | - |
Net loss attributable to Sorrento | |||||||||
-292,068 | -203,540 | 9,132 | -60,923 | -45,811 | -34,657 | -21,911 | -4,845 | -3,236 | -1,808 |
Net loss per share - basic and diluted per share attributable to Sorrento (in dollars per share) | |||||||||
- | - | - | - | - | -1.30 | -1.46 | -0.42 | -0.01 | -0.01 |
Weighted-average shares used during period - basic and diluted per share attributable to Sorrento (in shares) | |||||||||
- | - | - | - | - | 26,679 | 15,046 | 11 | - | - |
Net loss per share - basic per share attributable to Sorrento (USD per share) | |||||||||
-2.20 | -1.92 | 0.13 | -1.21 | -1.24 | - | - | - | - | - |
Net loss per share - diluted per share attributable to Sorrento (USD per share) | |||||||||
-2.35 | -1.92 | 0.13 | -1.21 | -1.24 | - | - | - | - | - |
Weighted-average shares used during period - basic per share attributable to Sorrento (in shares) | |||||||||
132,732 | 106,150 | 69,742 | 50,360 | 36,909 | - | - | - | - | - |
Weighted-average shares used during period - diluted per share attributable to Sorrento (in shares) | |||||||||
140,514 | 106,150 | 70,381 | 50,360 | 36,909 | - | - | - | - | - |
Weighted average number of shares during the period - basic and diluted | |||||||||
- | - | - | - | - | - | - | - | 248,048 | 220,849 |
Product | |||||||||
Revenues | |||||||||
21,974 | 5,873 | 553 | - | - | - | - | - | - | - |
Cost of products sold and services | |||||||||
5,933 | 1,476 | 0 | - | - | - | - | - | - | - |
Service | |||||||||
Revenues | |||||||||
9,458 | 15,320 | 151,303 | - | - | - | - | - | - | - |
Cost of products sold and services | |||||||||
6,304 | 5,584 | 3,945 | - | - | - | - | - | - | - |
Grant | |||||||||
Revenue from Contract with Customer, Including Assessed Tax | |||||||||
- | - | - | 1,033 | - | - | - | - | - | - |
Royalty and license | |||||||||
Total revenues | |||||||||
- | - | - | 4,017 | - | - | - | - | - | - |
Product And Service [Member] | |||||||||
Total revenues | |||||||||
- | - | - | 3,102 | - | - | - | - | - | - |